UNSPSC 51271631: Lidocaine hydrochloride monohydrate

This classification denotes a cation channel blocker and anesthetic agent with the molecular formula C14H22N2O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V13007Z41A, chemically known as acetamide, 2-(diethylamino)-n-(2,6-dimethylphenyl)-, monohydrochloride, monohydrate, but more generally known as lidocaine hydrochloride monohydrate, which bears US NIH Compound Identifier 22483.

European Medicines Agency schedules lidocaine hydrochloride monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08507MIG. Most nations, for tariff purposes, schedule lidocaine hydrochloride monohydrate under HS 29242910. SMILES: CCN(CC)CC(=O)NC1C(CCCC1C)C.O.CL.

UNSPSC 51271631 Lidocaine hydrochloride monohydrate is a Commodity code covering the procurement of this local anesthetic pharmaceutical in its monohydrate salt form, used in medical, dental, and emergency-response settings by state and local health agencies, correctional facilities, and emergency medical services. State and local governments purchase lidocaine hydrochloride monohydrate for wound infiltration, topical numbing applications, and emergency cardiac protocols where the specific salt formulation meets regulatory or clinical specifications.

The source does not identify recent state and local contract opportunities under this code. No issuing bodies, response dates, notice types, or geographic activity are documented in the available record.